Dr. Jacques Michaud

Professor

Build a Statement of Purpose

Generate a tailored SOP for Dr. Jacques Michaud. Improve your application with a focused, well-structured draft.

Biography

Professor Jacques Michaud's research primarily focuses on the biochemical characterization of medically relevant enzymes and their mechanisms of action. His work aims to uncover the regulatory mechanisms underlying enzyme activity and identify compounds that can modulate these activities. A significant area of his current research includes deubiquitinating enzymes, which play critical roles in regulating various biological processes by modifying cellular proteins through ubiquitination. His team utilizes enzyme kinetic techniques to study molecular mechanisms and the structure-function relationships of enzymes. Additionally, he investigates the pathogenicity of enzymes produced by Clostridium difficile and their impact on bacterial virulence and antibiotic resistance. Professor Michaud has supervised numerous graduate students and has led various research projects, including studies on rare genetic diseases and the effects of genomic variants on cognitive and behavioral traits. His extensive contributions to the field aim to facilitate the design of new therapeutic agents and improve understanding of neurodevelopmental disorders.

Research Interests

Experience

Professor

2005-01-01 — Present

Université de Montréal • Montréal, QC, Canada

Leading research in health sciences related to enzymatic mechanisms and neurodevelopmental disorders.

Requirements for Université de Montréal

Doctorate Program
Requirements
GPA Requirement
Required:3.3
TOEFL
Listening
Required:20
Reading
Required:20
Writing
Required:20
Speaking
Required:20
Total
Required:90
Prerequisites
MSc in Pharmacology or equivalent Research supervisor confirmation
Application Checklist
  • Transcripts
  • Birth certificate
  • Curriculum Vitae
  • Proof of French proficiency (B2/C1)
Specialization Notes

Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.